Table 1 TCR Vβ expression on CD4+ T cells (%) from lung and spleen of HUVEC and HUVEC-pristane treated rats (n = 4).
From: Immunomodulatory strategies prevent the development of autoimmune emphysema
|  | Vβ16.1 | Vβ10 | Vβ8.5 | |||
|---|---|---|---|---|---|---|
Experimental Groups (n = 4) | lung | spleen | lung | spleen | lung | spleen |
Control | 12.1 ± 0.34 | 12.7 ± 0.34 | 9.7 ± 0.29 | 9.2 ± 0.59 | 4.2 ± 0.414 | 4.4 ± 0.59 |
HUVEC* | 11.5 ± 0.88 | 12.1 ± 0.4 | 8.22 ± 0.34 | 8.08 ± 0.61 | 7.1 ± 1.27 | 8.4 ± 2.41 |
HUVEC+Pristane* | 7.67 ± 0.47 | 9.05 ± 0.59 | 7.1 ± 0.77 | 5.62 ± 1.68 | 7.79 ± 1.32 | 5.7 ± 1.82 |
|  | *p ≤ 0.008 | *p ≤ 0.003 | *p ≥ 0.05 | *p ≥ 0.05 | *p ≥ 0.05 | *p ≥ 0.05 |